APO Research
Talk to an analyst

APO RESEARCH · REPORT

RAF Proto Oncogene Serine & Threonine Protein Kinase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchRAF Proto Oncogene Serine & Threonine Protein Kinase Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal RAF Proto Oncogene Serine & Threonine Protein Kinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RAF Proto Oncogene Serine & Threonine Protein Kinase Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal RAF Proto Oncogene Serine & Threonine Protein Kinase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global RAF Proto Oncogene Serine & Threonine Protein Kinase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for RAF Proto Oncogene Serine & Threonine Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RAF Proto Oncogene Serine & Threonine Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RAF Proto Oncogene Serine & Threonine Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RAF Proto Oncogene Serine & Threonine Protein Kinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RAF Proto Oncogene Serine & Threonine Protein Kinase include Novartis AG, Eli Lilly and Company, Hanmi Pharmaceuticals, Co. Ltd., VG Life Sciences, Inc., Sirnaomics, Inc., Redx Pharma Plc, Millennium Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. and Basilea Pharmaceutica AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global RAF Proto Oncogene Serine & Threonine Protein Kinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RAF Proto Oncogene Serine & Threonine Protein Kinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RAF Proto Oncogene Serine & Threonine Protein Kinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RAF Proto Oncogene Serine & Threonine Protein Kinase market size, projected growth trends, production technologies, key applications, and end-use industries.

RAF Proto Oncogene Serine & Threonine Protein Kinase Segment by Company

Novartis AG

Eli Lilly and Company

Hanmi Pharmaceuticals, Co. Ltd.

VG Life Sciences, Inc.

Sirnaomics, Inc.

Redx Pharma Plc

Millennium Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd.

Basilea Pharmaceutica AG

RAF Proto Oncogene Serine & Threonine Protein Kinase Segment by Type

BAL-3833

DCBCI-0902

HM-95573

LXH-254

Others

RAF Proto Oncogene Serine & Threonine Protein Kinase Segment by Application

Solid Tumor

Colorectal Cancer

Liver Cancer

Lung Adenocarcinoma

Others

RAF Proto Oncogene Serine & Threonine Protein Kinase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RAF Proto Oncogene Serine & Threonine Protein Kinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RAF Proto Oncogene Serine & Threonine Protein Kinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RAF Proto Oncogene Serine & Threonine Protein Kinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the RAF Proto Oncogene Serine & Threonine Protein Kinase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RAF Proto Oncogene Serine & Threonine Protein Kinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of RAF Proto Oncogene Serine & Threonine Protein Kinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of RAF Proto Oncogene Serine & Threonine Protein Kinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Trends Table 2. RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Drivers Table 3. RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Opportunities and Challenges Table 4. RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Restraints Table 5. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Manufacturers Table 9. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Manufacturers, Product Type & Application Table 13. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global RAF Proto Oncogene Serine & Threonine Protein Kinase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BAL-3833 Table 17. Major Manufacturers of DCBCI-0902 Table 18. Major Manufacturers of HM-95573 Table 19. Major Manufacturers of LXH-254 Table 20. Major Manufacturers of Others Table 21. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type (2021-2026) & (K Units) Table 23. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type (2027-2032) & (K Units) Table 24. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Type (2021-2026) Table 25. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Type (2027-2032) Table 26. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type (2021-2026) & (K Units) Table 28. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type (2027-2032) & (K Units) Table 29. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Type (2021-2026) Table 30. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Solid Tumor Table 32. Major Manufacturers of Colorectal Cancer Table 33. Major Manufacturers of Liver Cancer Table 34. Major Manufacturers of Lung Adenocarcinoma Table 35. Major Manufacturers of Others Table 36. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application (2021-2026) & (K Units) Table 38. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application (2027-2032) & (K Units) Table 39. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Application (2021-2026) Table 40. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Application (2027-2032) Table 41. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application (2021-2026) & (K Units) Table 43. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application (2027-2032) & (K Units) Table 44. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Application (2021-2026) Table 45. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Application (2027-2032) Table 46. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region (2021-2026) & (K Units) Table 48. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Region (2021-2026) Table 49. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Forecasted Market Share by Region (2027-2032) Table 51. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2026) & (K Units) Table 53. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2027-2032) & (K Units) Table 54. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2026) & (K Units) Table 56. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2027-2032) & (K Units) Table 63. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region (2021-2026) & (US$ Million) Table 65. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region (2027-2032) & (US$ Million) Table 66. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Region (2021-2026) Table 67. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Region (2027-2032) Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis AG RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 72. Novartis AG Recent Development Table 73. Eli Lilly and Company Company Information Table 74. Eli Lilly and Company Business Overview Table 75. Eli Lilly and Company RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eli Lilly and Company RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 77. Eli Lilly and Company Recent Development Table 78. Hanmi Pharmaceuticals, Co. Ltd. Company Information Table 79. Hanmi Pharmaceuticals, Co. Ltd. Business Overview Table 80. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 82. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 83. VG Life Sciences, Inc. Company Information Table 84. VG Life Sciences, Inc. Business Overview Table 85. VG Life Sciences, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. VG Life Sciences, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 87. VG Life Sciences, Inc. Recent Development Table 88. Sirnaomics, Inc. Company Information Table 89. Sirnaomics, Inc. Business Overview Table 90. Sirnaomics, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sirnaomics, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 92. Sirnaomics, Inc. Recent Development Table 93. Redx Pharma Plc Company Information Table 94. Redx Pharma Plc Business Overview Table 95. Redx Pharma Plc RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Redx Pharma Plc RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 97. Redx Pharma Plc Recent Development Table 98. Millennium Pharmaceuticals, Inc. Company Information Table 99. Millennium Pharmaceuticals, Inc. Business Overview Table 100. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 102. Millennium Pharmaceuticals, Inc. Recent Development Table 103. F. Hoffmann-La Roche Ltd. Company Information Table 104. F. Hoffmann-La Roche Ltd. Business Overview Table 105. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 107. F. Hoffmann-La Roche Ltd. Recent Development Table 108. Basilea Pharmaceutica AG Company Information Table 109. Basilea Pharmaceutica AG Business Overview Table 110. Basilea Pharmaceutica AG RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Basilea Pharmaceutica AG RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio Table 112. Basilea Pharmaceutica AG Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. RAF Proto Oncogene Serine & Threonine Protein Kinase Distributors List Table 116. RAF Proto Oncogene Serine & Threonine Protein Kinase Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Image Figure 2. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Size (2021-2032) & (US$ Million) Figure 4. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales (2021-2032) & (K Units) Figure 5. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 RAF Proto Oncogene Serine & Threonine Protein Kinase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BAL-3833 Image Figure 9. DCBCI-0902 Image Figure 10. HM-95573 Image Figure 11. LXH-254 Image Figure 12. Others Image Figure 13. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Type (2021-2032) Figure 16. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Type (2021-2032) Figure 19. Solid Tumor Image Figure 20. Colorectal Cancer Image Figure 21. Liver Cancer Image Figure 22. Lung Adenocarcinoma Image Figure 23. Others Image Figure 24. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Application (2021-2032) Figure 27. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Application (2021-2032) Figure 30. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Country (2021-2032) Figure 32. U.S. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Country (2021-2032) Figure 37. Germany RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Country (2021-2032) Figure 44. China RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Country (2021-2032) Figure 52. Brazil RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile RAF Proto Oncogene Serine & Threonine Protein Kinase Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032) & (US$ Million) Figure 63. North America RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032) & (US$ Million) Figure 65. Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. RAF Proto Oncogene Serine & Threonine Protein Kinase Value Chain Figure 71. Manufacturing Cost Structure Figure 72. RAF Proto Oncogene Serine & Threonine Protein Kinase Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BAL-3833
  • DCBCI-0902
  • HM-95573
  • LXH-254
  • Others
Applications
  • Solid Tumor
  • Colorectal Cancer
  • Liver Cancer
  • Lung Adenocarcinoma
  • Others
Companies covered
  • Novartis AG
  • Eli Lilly and Company
  • Hanmi Pharmaceuticals, Co. Ltd.
  • VG Life Sciences, Inc.
  • Sirnaomics, Inc.
  • Redx Pharma Plc
  • Millennium Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Basilea Pharmaceutica AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market Dynamics
  1. 2.1 RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Trends
  2. 2.2 RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Drivers
  3. 2.3 RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Opportunities and Challenges
  4. 2.4 RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Restraints
3 RAF Proto Oncogene Serine & Threonine Protein Kinase Market by Manufacturers
  1. 3.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Manufacturers (2021-2026)
  3. 3.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Manufacturers, Product Type & Application
  7. 3.7 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RAF Proto Oncogene Serine & Threonine Protein Kinase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RAF Proto Oncogene Serine & Threonine Protein Kinase Tier 1, Tier 2, and Tier 3
4 RAF Proto Oncogene Serine & Threonine Protein Kinase Market by Type
  1. 4.1 RAF Proto Oncogene Serine & Threonine Protein Kinase Type Introduction
  2. 4.1.1 BAL-3833
  3. 4.1.2 DCBCI-0902
  4. 4.1.3 HM-95573
  5. 4.1.4 LXH-254
  6. 4.1.5 Others
  7. 4.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type
  8. 4.2.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Type (2021-2032)
  10. 4.2.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Type (2021-2032)
  11. 4.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type
  12. 4.3.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Type (2021-2032)
  14. 4.3.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Type (2021-2032)
5 RAF Proto Oncogene Serine & Threonine Protein Kinase Market by Application
  1. 5.1 RAF Proto Oncogene Serine & Threonine Protein Kinase Application Introduction
  2. 5.1.1 Solid Tumor
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Liver Cancer
  5. 5.1.4 Lung Adenocarcinoma
  6. 5.1.5 Others
  7. 5.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application
  8. 5.2.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Application (2021-2032)
  10. 5.2.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Market Share by Application (2021-2032)
  11. 5.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application
  12. 5.3.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Application (2021-2032)
  14. 5.3.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Application (2021-2032)
6 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region
  1. 6.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region (2021-2032)
  3. 6.2.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Region (2021-2026)
  4. 6.2.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region
  1. 7.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region
  2. 7.1.1 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region (2021-2026)
  4. 7.1.3 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue by Region (2027-2032)
  5. 7.1.4 Global RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032)
  8. 7.2.2 North America RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032)
  11. 7.3.2 Europe RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa RAF Proto Oncogene Serine & Threonine Protein Kinase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Eli Lilly and Company
  8. 8.2.1 Eli Lilly and Company Company Information
  9. 8.2.2 Eli Lilly and Company Business Overview
  10. 8.2.3 Eli Lilly and Company RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Company RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  12. 8.2.5 Eli Lilly and Company Recent Developments
  13. 8.3 Hanmi Pharmaceuticals, Co. Ltd.
  14. 8.3.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  15. 8.3.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
  16. 8.3.3 Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hanmi Pharmaceuticals, Co. Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  18. 8.3.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
  19. 8.4 VG Life Sciences, Inc.
  20. 8.4.1 VG Life Sciences, Inc. Company Information
  21. 8.4.2 VG Life Sciences, Inc. Business Overview
  22. 8.4.3 VG Life Sciences, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 VG Life Sciences, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  24. 8.4.5 VG Life Sciences, Inc. Recent Developments
  25. 8.5 Sirnaomics, Inc.
  26. 8.5.1 Sirnaomics, Inc. Company Information
  27. 8.5.2 Sirnaomics, Inc. Business Overview
  28. 8.5.3 Sirnaomics, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sirnaomics, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  30. 8.5.5 Sirnaomics, Inc. Recent Developments
  31. 8.6 Redx Pharma Plc
  32. 8.6.1 Redx Pharma Plc Company Information
  33. 8.6.2 Redx Pharma Plc Business Overview
  34. 8.6.3 Redx Pharma Plc RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Redx Pharma Plc RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  36. 8.6.5 Redx Pharma Plc Recent Developments
  37. 8.7 Millennium Pharmaceuticals, Inc.
  38. 8.7.1 Millennium Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Millennium Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Millennium Pharmaceuticals, Inc. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  42. 8.7.5 Millennium Pharmaceuticals, Inc. Recent Developments
  43. 8.8 F. Hoffmann-La Roche Ltd.
  44. 8.8.1 F. Hoffmann-La Roche Ltd. Company Information
  45. 8.8.2 F. Hoffmann-La Roche Ltd. Business Overview
  46. 8.8.3 F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 F. Hoffmann-La Roche Ltd. RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  48. 8.8.5 F. Hoffmann-La Roche Ltd. Recent Developments
  49. 8.9 Basilea Pharmaceutica AG
  50. 8.9.1 Basilea Pharmaceutica AG Company Information
  51. 8.9.2 Basilea Pharmaceutica AG Business Overview
  52. 8.9.3 Basilea Pharmaceutica AG RAF Proto Oncogene Serine & Threonine Protein Kinase Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Basilea Pharmaceutica AG RAF Proto Oncogene Serine & Threonine Protein Kinase Product Portfolio
  54. 8.9.5 Basilea Pharmaceutica AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 RAF Proto Oncogene Serine & Threonine Protein Kinase Value Chain Analysis
  2. 9.1.1 RAF Proto Oncogene Serine & Threonine Protein Kinase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 RAF Proto Oncogene Serine & Threonine Protein Kinase Production Mode & Process
  6. 9.2 RAF Proto Oncogene Serine & Threonine Protein Kinase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 RAF Proto Oncogene Serine & Threonine Protein Kinase Distributors
  9. 9.2.3 RAF Proto Oncogene Serine & Threonine Protein Kinase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst